Upper Airway Alarmin Cytokine Expression in Asthma of Different Severities
Journal of Clinical Medicine · 26.06.2024 · 13 (13) · 3721
DOI: 10.3390/jcm13133721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.06.2024. Verfasst von Hazel Marriott und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca (Canada), AstraZeneca Ltd..
Abstract (Originalsprache)
Background
The secretion of alarmin cytokines by epithelial cells, including thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33, initiates inflammatory cascades in asthma. However, alarmin cytokine expression in the upper airways in asthma remains largely unknown.
Methods
We recruited 40 participants with asthma into four groups as per the Global Initiative for Asthma (GINA) steps (10 in each group of GINA 1/2, 3, 4, and 5). Cells were derived from nasal, buccal, and throat brushings. Intracellular cytokine expression (TSLP, IL-25, and IL-33) was assessed by flow cytometry in cytokeratin 8+ (Ck8+) epithelial cells immediately following collection.
Results
TSLP was significantly increased (p < 0.001) in GINA 5 patients across nasal, buccal, and throat Ck8+ epithelial cells, while IL-25 was elevated in nasal and throat samples (p < 0.003), and IL-33 levels were variable, compared with GINA 1–4 patients. Individual GINA subgroup comparison showed that TSLP levels in nasal samples from GINA 5 patients were significantly (p = 0.03) elevated but did not differ between patients with and without nasal comorbidities. IL-25 and IL-33 (obtained from nasal, buccal, and throat samples) were not significantly different in individual groups.
Conclusions
Our study demonstrates for the first time that Ck8+ nasal epithelial cells from GINA 5 asthma patients express elevated levels of TSLP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada.
ORCID-Profile: Hazel Marriott, Marc Duchesne, Subhabrata Moitra, Irvin Mayers, Adil Adatia, Paige Lacy
Förderung
- AstraZeneca (Canada)
- AstraZeneca Ltd.
Zitieren
APA
Marriott, H., Duchesne, M., Moitra, S., Okoye, I., Gerla, L., Mayers, I., Moolji, J., Adatia, A., & Lacy, P. (2024). Upper Airway Alarmin Cytokine Expression in Asthma of Different Severities. Journal of Clinical Medicine, 13(13), 3721. https://doi.org/10.3390/jcm13133721
Vancouver
Marriott H, Duchesne M, Moitra S, Okoye I, Gerla L, Mayers I, et al. Upper Airway Alarmin Cytokine Expression in Asthma of Different Severities. Journal of Clinical Medicine. 2024;13(13):3721. doi:10.3390/jcm13133721
BibTeX
@article{Marriott2024,
author = {Marriott, Hazel and Duchesne, Marc and Moitra, Subhabrata and Okoye, Isobel and Gerla, Luke and Mayers, Irvin and Moolji, Jalal and Adatia, Adil and Lacy, Paige},
title = {Upper Airway Alarmin Cytokine Expression in Asthma of Different Severities},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {13},
pages = {3721},
doi = {10.3390/jcm13133721}
}
EUVIMED